Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02703896Phase 4Completed
Phase 4, randomised, triple-blind trial of omeprazole, lansoprazole, esomeprazole, rabeprazole, pantoprazole and 5 more in pulmonary aspiration (4 arms), sponsored by King Saud University. Primary endpoint: pH of gastric contents. Started Jan 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02703896.